Spinevision SAS
$66.0K 12 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Pathway Medical Partners, LLC
Pathway Medical Partners, LLC reported $66,000.00 across General Payments, Research, and Ownership to 33 physicians and teaching hospitals across 33 transactions.
- $66.0K Below-median payer
- All-tracks total
- 33 Below-median volume
- Transactions
- 33 Below-median reach
- Recipients
- +$50.0K
- General Payments vs PY2023
Pathway Medical Partners, LLC reported $66,000.00 across all CMS Open Payments tracks (General + Research + Ownership) to 33 physicians and teaching hospitals in Program Year 2024 - ranking #1281 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $66,000.00, averaging $2.0K per recipient.
Pathway Medical Partners, LLC's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
10/100
Total payments
F
11/100
Transaction volume
F
10/100
Physician reach
F
10/100
Payment type diversity
F
10/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer pathway-medical-partners-llc Pathway Medical Partners, LLC
$66.0K · #1281/1,925 · 0.0% industry · PY2024
- TOT $66.0K
- RANK #1281
- SHARE 0.0%
- TXN 33
- RCP 33
- CAT 1
- GEN $66.0K
- ΔGEN +$50.0K
- TOP1 20.0%
- PY 2024
Volume peers
Nearest volume peer: Spinevision SAS ($66.0K)
Pathway Medical Partners, LLC sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Pathway Medical Partners, LLC's CMS-reported General Payments increased by $50.0K (+312.5%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2023: PATHWAY MEDICAL PARTNERS, LLCPY2024: Pathway Medical Partners, LLC. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $16,000.00
- PY2024
- $66,000.00
What the Data Shows for Pathway Medical Partners, LLC
CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For Pathway Medical Partners, LLC that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.
Of the 1 general-payment categories charted below, "Education" is the largest at $66.0K across 33 transactions, 100.0% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Across 1 types of general payments, Pathway Medical Partners, LLC's largest category was "Education" at $66.0K - 100.0% of General Payments.
How Pathway Medical Partners, LLC divides its payments
How the reported total splits across payment categories
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Education | $66.0K | 33 | 100.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $44,000.00 (66.7%) of $66,000.00 in this company's General Payments records across 12 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Pathway Medical Partners, LLC
The five named recipients with the highest reported General Payments from this company
- 1
Brian Burgess
$13,200.00 across 6 reported transactions
- 2
Moiz Hassan
$8,000.00 across 4 reported transactions
- 3
Steven Jasonowicz
$8,000.00 across 4 reported transactions
- 4
Jonathan Hook
$8,000.00 across 4 reported transactions
- 5
Alexander Mckanna
$6,800.00 across 4 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Pathway Medical Partners, LLC's spend rank (#1281 of 1,925, bottom 34% by spend) and concentration rank (#971 of 1,838, bottom 47% least concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.
View all 12 companies in this HHI neighborhood as a list
- Pulpdent Corporation : $80.0K total payments, HHI 1162
- Optos, Inc. : $585.3K total payments, HHI 1153
- HemoSonics LLC : $100.7K total payments, HHI 1152
- Intercept Pharmaceuticals, Inc. : $2.8M total payments, HHI 1149
- Asensus Surgical, Inc. : $207.1K total payments, HHI 1147
- Alcresta Therapeutics, Inc. : $170.2K total payments, HHI 1141
- Pathway Medical Partners, LLC (this company) : $66.0K total payments, HHI 1140
- Visionix USA, Inc : $108.9K total payments, HHI 1138
- Anika Therapeutics, Inc. : $1.1M total payments, HHI 1135
- Woven Orthopedic Technologies, LLC : $1.2K total payments, HHI 1134
- MY01 Inc. : $29.5K total payments, HHI 1134
- Whitehall International Inc : $44.4K total payments, HHI 1133
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Pathway Medical Partners, LLC's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Pathway Medical Partners, LLC.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Pathway Medical Partners, LLC.
Showing 6 of 1,924 companies with CMS-reported payment data.
Cambridge Interventional LLC
$66.1K 36 recipients
Compare payment profiles
Valinor Pharma, LLC
$65.8K 4,160 recipients
Compare payment profiles
SS White Burs, Inc.
$65.6K 105 recipients
Compare payment profiles
Swan Valley Medical Incorporated
$65.3K 7 recipients
Compare payment profiles
Momentis Surgical Inc.
$66.7K 21 recipients
Compare payment profiles
Put this to use
Pathway Medical Partners, LLC ranks #1281 of 1,925 by all-tracks total payments, led by "Education".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Education" spend across every manufacturer, not just Pathway Medical Partners, LLC. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.